Aerovate Therapeutics Inc - ESG Rating & Company Profile powered by AI
This dashboard contains a questions and answers section on Aerovate Therapeutics Inc. The Disclosure score covers 17 UN SDGs including: 'Good Health & Wellbeing', 'Decent Work & Economic Growth' and 'Peace, Justice & Strong Institutions'. If you are employed by Aerovate Therapeutics Inc and you would like to licence your ESG rating, please contact us.
Aerovate Therapeutics Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 3.4; made up of an environmental score of 2.7, social score of 1.6 and governance score of 6.0.
3.4
Low ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| ... | ... | ... | |
| 1186 | Simply Better Brands Corp | 3.5 | Medium |
| 1186 | Yunnan Baiyao Group Co Ltd | 3.5 | Medium |
| 1234 | Aerovate Therapeutics Inc | 3.4 | Medium |
| 1234 | Cassava Sciences Inc | 3.4 | Medium |
| 1234 | Brickell Biotech Inc | 3.4 | Medium |
| ... | ... | ... | |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Aerovate Therapeutics Inc have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Aerovate Therapeutics Inc disclose current and historical energy intensity?
Sign up for free to unlockDoes Aerovate Therapeutics Inc report the average age of the workforce?
Sign up for free to unlockDoes Aerovate Therapeutics Inc reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Aerovate Therapeutics Inc disclose its ethnicity pay gap?
Sign up for free to unlockDoes Aerovate Therapeutics Inc disclose cybersecurity risks?
Sign up for free to unlockDoes Aerovate Therapeutics Inc offer flexible work?
Sign up for free to unlockDoes Aerovate Therapeutics Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Aerovate Therapeutics Inc disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Aerovate Therapeutics Inc conduct supply chain audits?
Sign up for free to unlockDoes Aerovate Therapeutics Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Aerovate Therapeutics Inc conduct 360 degree staff reviews?
Sign up for free to unlockDoes Aerovate Therapeutics Inc disclose the individual responsible for D&I?
Sign up for free to unlockDoes Aerovate Therapeutics Inc disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Aerovate Therapeutics Inc disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Aerovate Therapeutics Inc disclose water use targets?
Sign up for free to unlockDoes Aerovate Therapeutics Inc have careers partnerships with academic institutions?
Sign up for free to unlockDid Aerovate Therapeutics Inc have a product recall in the last two years?
Sign up for free to unlockDoes Aerovate Therapeutics Inc disclose incidents of discrimination?
Sign up for free to unlockDoes Aerovate Therapeutics Inc allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Aerovate Therapeutics Inc issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Aerovate Therapeutics Inc disclose parental leave metrics?
Sign up for free to unlockDoes Aerovate Therapeutics Inc disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Aerovate Therapeutics Inc disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Aerovate Therapeutics Inc disclose the pay ratio of women to men?
Sign up for free to unlockDoes Aerovate Therapeutics Inc support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Aerovate Therapeutics Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Aerovate Therapeutics Inc reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Aerovate Therapeutics Inc involved in embryonic stem cell research?
Sign up for free to unlockDoes Aerovate Therapeutics Inc disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Aerovate Therapeutics Inc disclose its waste policy?
Sign up for free to unlockDoes Aerovate Therapeutics Inc report according to TCFD requirements?
Sign up for free to unlockDoes Aerovate Therapeutics Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Aerovate Therapeutics Inc disclose energy use targets?
Sign up for free to unlockDoes Aerovate Therapeutics Inc disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Aerovate Therapeutics Inc have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Aerovate Therapeutics Inc
These potential risks are based on the size, segment and geographies of the company.
Aerovate Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of drugs that enhance the lives of patients with rare cardiopulmonary diseases in the United States. The company focuses on advancing AV-101, a dry powder inhaled formulation of imatinib for the treatment of pulmonary arterial hypertension, which is in Phase 2b/Phase 3 trial. Aerovate Therapeutics, Inc. was incorporated in 2018 and is headquartered in Waltham, Massachusetts.